Company Filing History:
Years Active: 2011
Title: Adewale Eniade: Innovator in Ion Channel Modulation
Introduction
Adewale Eniade is a notable inventor based in Coquitlam, Canada. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of prodrugs that modulate ion channels. His work is essential for advancing therapeutic options in various medical conditions.
Latest Patents
Adewale Eniade holds a patent for "Prodrugs of ion channel modulating compounds and uses thereof." This patent describes prodrugs of ion channel modulating compounds, including methods of making and using such prodrugs, as well as pharmaceutical compositions containing them. His innovative approach aims to enhance the efficacy and safety of ion channel therapies.
Career Highlights
Adewale Eniade is currently associated with Cardiome Pharma Corp., where he applies his expertise in drug development. His work at the company focuses on creating advanced therapeutic solutions that address critical health issues. With a patent portfolio that includes 1 patent, he continues to contribute to the scientific community.
Collaborations
Adewale collaborates with esteemed colleagues such as Lewis Siu Leung Choi and Doug Ta Hung Chou. These partnerships enhance the research and development efforts at Cardiome Pharma Corp., fostering innovation in the pharmaceutical industry.
Conclusion
Adewale Eniade is a prominent figure in the field of ion channel modulation, with a focus on developing prodrugs that can significantly impact patient care. His contributions through patents and collaborations highlight his commitment to advancing medical science.